Literature DB >> 33510772

Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients' Brain in a Dish.

Suleva Povea-Cabello1, Marina Villanueva-Paz2, Juan M Suárez-Rivero1, Mónica Álvarez-Córdoba1, Irene Villalón-García1, Marta Talaverón-Rey1, Alejandra Suárez-Carrillo1, Manuel Munuera-Cabeza1, José A Sánchez-Alcázar1.   

Abstract

Mitochondrial diseases are a heterogeneous group of rare genetic disorders that can be caused by mutations in nuclear (nDNA) or mitochondrial DNA (mtDNA). Mutations in mtDNA are associated with several maternally inherited genetic diseases, with mitochondrial dysfunction as a main pathological feature. These diseases, although frequently multisystemic, mainly affect organs that require large amounts of energy such as the brain and the skeletal muscle. In contrast to the difficulty of obtaining neuronal and muscle cell models, the development of induced pluripotent stem cells (iPSCs) has shed light on the study of mitochondrial diseases. However, it is still a challenge to obtain an appropriate cellular model in order to find new therapeutic options for people suffering from these diseases. In this review, we deepen the knowledge in the current models for the most studied mt-tRNA mutation-caused mitochondrial diseases, MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) and MERRF (myoclonic epilepsy with ragged red fibers) syndromes, and their therapeutic management. In particular, we will discuss the development of a novel model for mitochondrial disease research that consists of induced neurons (iNs) generated by direct reprogramming of fibroblasts derived from patients suffering from MERRF syndrome. We hypothesize that iNs will be helpful for mitochondrial disease modeling, since they could mimic patient's neuron pathophysiology and give us the opportunity to correct the alterations in one of the most affected cellular types in these disorders.
Copyright © 2021 Povea-Cabello, Villanueva-Paz, Suárez-Rivero, Álvarez-Córdoba, Villalón-García, Talaverón-Rey, Suárez-Carrillo, Munuera-Cabeza and Sánchez-Alcázar.

Entities:  

Keywords:  direct reprogramming; disease modeling; induced neurons; mitochondrial diseases; mtDNA

Year:  2021        PMID: 33510772      PMCID: PMC7835939          DOI: 10.3389/fgene.2020.610764

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  127 in total

1.  MicroRNA-mediated conversion of human fibroblasts to neurons.

Authors:  Andrew S Yoo; Alfred X Sun; Li Li; Aleksandr Shcheglovitov; Thomas Portmann; Yulong Li; Chris Lee-Messer; Ricardo E Dolmetsch; Richard W Tsien; Gerald R Crabtree
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

2.  Recovery of MERRF fibroblasts and cybrids pathophysiology by coenzyme Q10.

Authors:  Mario De la Mata; Juan Garrido-Maraver; David Cotán; Mario D Cordero; Manuel Oropesa-Ávila; Lourdes Gómez Izquierdo; Manuel De Miguel; Juan Bautista Lorite; Eloy Rivas Infante; Patricia Ybot; Sandra Jackson; José A Sánchez-Alcázar
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

3.  Treatment of human cells derived from MERRF syndrome by peptide-mediated mitochondrial delivery.

Authors:  Jui-Chih Chang; Ko-Hung Liu; Chieh-Sen Chuang; Hong-Lin Su; Yau-Huei Wei; Shou-Jen Kuo; Chin-San Liu
Journal:  Cytotherapy       Date:  2013-12       Impact factor: 5.414

Review 4.  Mitochondrial Function, Biology, and Role in Disease: A Scientific Statement From the American Heart Association.

Authors:  Elizabeth Murphy; Hossein Ardehali; Robert S Balaban; Fabio DiLisa; Gerald W Dorn; Richard N Kitsis; Kinya Otsu; Peipei Ping; Rosario Rizzuto; Michael N Sack; Douglas Wallace; Richard J Youle
Journal:  Circ Res       Date:  2016-04-28       Impact factor: 17.367

Review 5.  Leber hereditary optic neuropathy: current perspectives.

Authors:  Cherise Meyerson; Greg Van Stavern; Collin McClelland
Journal:  Clin Ophthalmol       Date:  2015-06-26

Review 6.  Mitochondrial DNA disease-molecular insights and potential routes to a cure.

Authors:  Oliver Russell; Doug Turnbull
Journal:  Exp Cell Res       Date:  2014-03-24       Impact factor: 3.905

Review 7.  Early onset cardiomyopathy associated with the mitochondrial tRNALeu((UUR)) 3271T>C MELAS mutation.

Authors:  Giacomo Brisca; Chiara Fiorillo; Claudia Nesti; Federica Trucco; Maria Derchi; Antonio Andaloro; Stefania Assereto; Guido Morcaldi; Marina Pedemonte; Carlo Minetti; Filippo M Santorelli; Claudio Bruno
Journal:  Biochem Biophys Res Commun       Date:  2015-02-11       Impact factor: 3.575

8.  A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease.

Authors:  Johanna H K Kauppila; Holly L Baines; Ana Bratic; Marie-Lune Simard; Christoph Freyer; Arnaud Mourier; Craig Stamp; Roberta Filograna; Nils-Göran Larsson; Laura C Greaves; James B Stewart
Journal:  Cell Rep       Date:  2016-09-13       Impact factor: 9.423

9.  Simple Generation of a High Yield Culture of Induced Neurons from Human Adult Skin Fibroblasts.

Authors:  Shelby Shrigley; Karolina Pircs; Roger A Barker; Malin Parmar; Janelle Drouin-Ouellet
Journal:  J Vis Exp       Date:  2018-02-05       Impact factor: 1.355

10.  Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo.

Authors:  Payam A Gammage; Carlo Viscomi; Marie-Lune Simard; Ana S H Costa; Edoardo Gaude; Christopher A Powell; Lindsey Van Haute; Beverly J McCann; Pedro Rebelo-Guiomar; Raffaele Cerutti; Lei Zhang; Edward J Rebar; Massimo Zeviani; Christian Frezza; James B Stewart; Michal Minczuk
Journal:  Nat Med       Date:  2018-09-24       Impact factor: 53.440

View more
  4 in total

Review 1.  The tRNA regulome in neurodevelopmental and neuropsychiatric disease.

Authors:  Jennifer Blaze; Schahram Akbarian
Journal:  Mol Psychiatry       Date:  2022-05-03       Impact factor: 15.992

Review 2.  Revealing the Impact of Mitochondrial Fitness During Early Neural Development Using Human Brain Organoids.

Authors:  Alejandra I Romero-Morales; Vivian Gama
Journal:  Front Mol Neurosci       Date:  2022-04-29       Impact factor: 6.261

3.  Late onset of type 2 diabetes is associated with mitochondrial tRNATrp A5514G and tRNASer(AGY) C12237T mutations.

Authors:  Liuchun Yang; Qinxian Guo; Jianhang Leng; Keyi Wang; Yu Ding
Journal:  J Clin Lab Anal       Date:  2021-11-22       Impact factor: 2.352

4.  The first two mitochondrial genomes for the genus Ramaria reveal mitochondrial genome evolution of Ramaria and phylogeny of Basidiomycota.

Authors:  Qiang Li; Lijiao Li; Ting Zhang; Peng Xiang; Qian Wu; Wenying Tu; Zhijie Bao; Liang Zou; Cheng Chen
Journal:  IMA Fungus       Date:  2022-09-13       Impact factor: 8.044

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.